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    In order to investigate the significance of human chorionic gonadotropin （hCG） in seminoma
of the testis， seru皿hCG Ievels in peripheral and testicular venous bloods befbre orchicctomy alld
hCG levels in tumor tissues were measured in 25 cases． Additionally， tissue specimens of seminomas
were iinmunohistochemically studied for the cellular localization of hCG by peroxidase antiperoxidase
（PAP） method． The results were as follows：
    1） The rates ef elevatiQn of serum hCG levels were 47．80／． in peripheral venous blood， and 88．80／，
in testicular venous blood．
   2） HCG levels in turnor tissues were detected in all cases， and their average level was 437．6 ngfg
tissue． ln case hCG levels in tumor tissues were less than 150 ng／g tissue， serum hCG were negative
both in testicular and peripheral venous bloods． However， in case showing the level more than 150
ng／g tissue， serum hCG in亡es亡icular venous blood were pos三tive， and if mote than 200 ng／g tissue，
serum hCG in peripheral venous blood were positive in all cases．
   3） By PAP method， hCG was demonstrated wi’thin syncytiotrophoblastic giant cell （STGC）
in 10 of 22 cases， and in 2 cases of 10， cellular localizations of hCG were foupd not only in STGC but
a］so in tumor cells of seminoma．
   4） ln positive group by PAP method， both serum hCG leVels and rates of elevation of serum
hCG levels in peripheral and testicular venous bloods were higher than negative group． And
the same result was obtained in hCG levels in tumor tissues．
   It was concluded that the measurement of serum hCG levels in periPheral venous blood before
orchiectomy is useful as a serum marker for seminoma． And STGC were mostly seen by PAP method
in the cases which showed high hCG levels before orchiectomy ameng the cases diagnosed as pure
seminolna histopathologically by he皿atoxylin－eosin stained specimen． Those should．．@bc reg’≠窒р?
as non－seminomatous germ cell tumor．
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0．01血01phosphate buffer saline（PBS） 1こ溶解てノ，
E二xtraction of Tissues
（D The tissues were homogenized with a
 Polytron at a c．oncentration of l gm
  tissue／5m2 0f glacial acetic acid．
          ，
＠ The homogenates were agitated in a
  water bath at 85‘C for 30min．
          ，
＠ Centrifuged at 12×103 cycle／min．
  for 30 min． at 4’C．
          ，
＠ The supernatants were lyophilized．
          ，
＠ Reconstituted in O．OI M PBS．
          ，
＠ Centrifuged at 12×10S cycle／min．
  for 30 min． at 40c．
          ；
O Aliquots of the supernatants were
  subjected to hCG一，e RIA．
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i・ React with rabbit antisera
 against hCG－ff （A）
蓋
：K］Ct
3 React with Peroxidase
 antiperoxidase CPAP）
2． React again with goat anti－rabbit lgG （B）
短
       N ／
        i£a
4 The reaction was visualized
 wi th DAB
               ｝1一／／一，bl．． U，i・  PAP             （B） i’：A”’・’：mp●邊こ．
               ｝，，X
     DAB ： Diamj”obetizidme






















































4 泌尿紀要 28巻 1号 1982年
Table 1． Cases of seminoma
  Cases of Seminoma
No． of hCGConcentratlons inCeIIuIar
CaseAgeStagePeripher81ue向ou58bod 丁esticularuenou5副oodTumorsi55ueLoca闘zationいg！mの （ngノ旧の ｛叩／9・しi55ロe1 of hCG
蕃 31 1 1．7 7 153 ＊
2 37 1 2．3 ＊ ＊ 十
3 39 1 2．6 ＊ 150 一
4 67 1 5 67 31ア 十
5 42 1 20 36 1判ア 十
6 30 1 25 80 ＊ 十
7 44 1 41．7 100 167 十
8 32 1 67 67 3333 十
9 36 皿 11．5 ＊ ＊ 一
10 27 皿 10 ＊ ＊ 十
11 35 皿 30 ＊ 200 十
12 26 1 ＊ ＊ 5．3 ＊
1ヨ 35 1 ＜0．8 ＊ 10 一
14 48 1 ＜0．8 ＊ 19 一
15 31 1 ＜0．8 ＊ 21 一
16 40 1 ＜0．8 ＜0．8 42 一
17 50 1 ＜0．8 5 150 十
18 34 1 く0．8 ＊ ＊ 一
19 41 1 ＜0．8 ＊ ＊ 一
20 35 1 ＊ ＊ 950 ＊
21 35 1 ＜0．8 ＊ ＊ 十
22 41 皿 ＜0．8 ＊ 167 一
23 34 ∬ ＜0．8 ＊ ＊ 一
24 31 1［ ＜0。8 ＊ ＊ 一
















































Table 2． Presence of hGG in sera and tumor
        tissues of seminoma patients
                Seminorna Pts．
 Peripheral Testicutar














88．9 ％ 100 ％
Seminoma Patients
hCG concentrations in sera and tumor
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  Fig．4． hCG found in syncytiotrophoblastic giant cell（STGC）
    in seminoma by PAP method
Fig． 5． hCG found in tumor cell of seminoma （SC） by PAP method











      hCG in hCG in
     Testicular Peripheral
    Venous Blood Venous Blood
Fig． 6． Relation of serum hCG concentrations
    in testicular and peripheral venous












































    positive 1 Negative
   for hCG in 1 for hCG in
    PVB 1 ， PVB
Comparison of tumor tissue hCG con－
centrations in two groups， postive and
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 （十） 1 （一）
Cellular Localization
Relationship between hCG concentrations in sera， tumor tissues
and cellular localization of hCG of seminoma patients
Table 3．
増田；Se童ninoma・hCG
Relationship between presece of hGG in sera， tumor tissues and
cellular ’localization of hCG of seminoma patients




（十） 1 （一） （十） 1 （一） （十） 1 （一）
No． Pts． 10










































































































































































































Table 4． Presence of hCG in sera and testes
     of normal control
        Normal Controt
9
ng／禧
   200







Venous副ood  Venous Blood
Testis
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       Normal Control
Fig． 9． hCG concentrations in sera and
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